AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 156 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $420,000 | +22.8% | 25,108 | +6.0% | 0.04% | -2.4% |
| Q1 2020 | $342,000 | -57.4% | 23,690 | -1.1% | 0.04% | -42.3% |
| Q4 2019 | $802,000 | +21.7% | 23,958 | -23.8% | 0.07% | +10.9% |
| Q3 2019 | $659,000 | +43.6% | 31,454 | +42.6% | 0.06% | +39.1% |
| Q2 2019 | $459,000 | +85.8% | 22,057 | +99.4% | 0.05% | +70.4% |
| Q1 2019 | $247,000 | -2.8% | 11,060 | +4.3% | 0.03% | -15.6% |
| Q4 2018 | $254,000 | -3.4% | 10,603 | +10.1% | 0.03% | +6.7% |
| Q3 2018 | $263,000 | -2.2% | 9,633 | -3.7% | 0.03% | -9.1% |
| Q2 2018 | $269,000 | -7.9% | 9,998 | +9.0% | 0.03% | -13.2% |
| Q1 2018 | $292,000 | – | 9,174 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |